Why do smokers have higher plasma fibrinogen levels than non-smokers?

Clinical Science

Volumn 101, Issue 2, 2001, Pages 209-210

  Lowe, G D O ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; SERUM ALBUMIN;

ATHEROGENESIS; BLOOD VISCOSITY; CARDIOVASCULAR RISK; DOSE RESPONSE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN SYNTHESIS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SMOKING CESSATION; SMOKING HABIT; THROMBOGENESIS;

CASE-CONTROL STUDIES; CORONARY DISEASE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOGEN; HUMANS; MALE; SMOKING; SMOKING CESSATION;

EID: 0034875322     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010156     Document Type: Note

References (19)

1. Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update
2. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease
3. Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study
4. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study
5. Fibrinogen as a risk factor for coronary heart disease and mortality in middle aged men and women: The Scottish Heart Health Study
6. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study
7. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study
8. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
9. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans
10. Haematocrit, viscosity, erthryocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease
11. Epidemiology of haematocrit, white cell count, red cell aggregation and fibrinogen: The Glasgow MONICA study
12. Acute changes in atherogenic and thrombogenic factors with cessation from smoking
13. Haemorheological changes in the short term after abstention from tobacco by cigarette smokers
14. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell Study. Are inflammation and fibrin turnover linked in pathogenesis ?
15. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease
16. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease
17. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study
18. Therapeutic interventions to lower plasma fibrinogen concentration